- Supported exchanges /
- LSE /
- 0O9B.LSE
Almirall (0O9B LSE) stock market data APIs
Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.
Almirall Financial Data Overview
| 8.5125 | |
| 8.545 | |
| - | |
| 9.5273 | |
| 8.5125 | |
| 7.643-9.97 | |
| 1 807 M | |
| 174 M | |
| 932 M | |
| 0 | |
| 0.0184 | |
| 0.388 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Almirall Fundamental Data is available in our Financial Data APIs
- Net Revenue 932 M
- EBITDA 150 M
- Earnings Per Share -0.279
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Almirall Earnings via APIs
- Latest Release 2024-05-13
- EPS/Forecast 0
Get Almirall End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
